Skip to content

Evaluation of the Longevity of Therapeutic Outcomes in Brow Ptosis Correction Using Barbed PDO-Mesh Threads Among Thai Individuals

Evaluation of the Longevity of Therapeutic Outcomes in Brow Ptosis Correction Using Barbed PDO-Mesh Threads Among Thai Individuals

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20250709007
Enrollment
15
Registered
2025-07-09
Start date
2025-06-10
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brow ptosis in Thai adults aged over 20 years Thread Lift Barbed Sutures Polydioxanone Mesh Brow Ptosis Facial Rejuvenation Patient Satisfaction Postoperative Complications Minimally Invasive Procedures Treatment Outcome Follow-Up Studies Time Factors

Interventions

This group includes participants with clinically diagnosed brow ptosis who underwent thread lifting using PDO-mesh with barbed structure. All participants received the procedure at S-Mart Anti-aging W
Treatment
Patients with brow ptosis treated with PDO-mesh barbed thread lifting

Sponsors

Eden Color (Thailand) Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Thai adults aged 20 years or older 2. Individuals with concerns regarding brow position 3. Willingness to participate and provide written informed consent 4. Completed barbed PDO-mesh thread lifting for brow ptosis before study enrollment

Exclusion criteria

Exclusion criteria: 1. Currently pregnant or breastfeeding 2. History of allergy to lidocaine or related compounds 3. History of hypertrophic scarring or keloid formation 4. Diagnosed with immunodeficiency or any chronic immune-related disease 5. Psychological disorder that may affect the ability to provide informed consent 6. Underlying connective tissue disorder 7. Active skin infection at the treatment area 8. Open wound at the treatment area 9. Abnormal blood coagulation 10. Use of anticoagulants or antiplatelet medications on a continuous basis

Design outcomes

Primary

MeasureTime frame
Brow position longevity Before treatment, Immediately after, Month 1, Month 2, Month 3, Month 6, Month 9, Month 12 VISIA images measured in ImageJ at head, mid, and tail of brow from a medial canthi line

Secondary

MeasureTime frame
Patient satisfaction Immediately post-treatment, Week 1, Week 2, Month 1, Month 2, Month 3, Month 6, Month 9, Month 12 GAIS scale,Early complications Immediately post-treatment, Week 1, Week 2, Month 1 Clinical assessment and patient report of adverse events

Countries

Thailand

Contacts

Public ContactJundanai Junlakarin

S-Mart Anti-aging Wellness Center

jundanai.j@docchula.com0871393555

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026